Expert recommends one fruit to eat daily to 'help maintain normal heart function'
Potassium is known to help lower blood pressure as it helps the body lose sodium through urine, easing tension on your blood vessels. (Source: Daily Express - Health)
Source: Daily Express - Health - December 14, 2022 Category: Consumer Health News Source Type: news
'Absolute disgrace!' Tory slams 'lastminute.com' Government for FINALLY responding to her report
A Government-commissioned report in 2020 looked into the victims of sodium valproate - which left thousands of British babies with birth defects or special needs. (Source: the Mail online | Health)
Source: the Mail online | Health - December 13, 2022 Category: Consumer Health News Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Lupin launches generic joint pain drug in US market
The company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement. As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2022 Category: Pharmaceuticals Source Type: news
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
WEDNESDAY, Dec. 7, 2022 -- For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-related adverse... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2022 Category: Pharmaceuticals Source Type: news
Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton due to Vial Breakage UPDATED November 28, 2022
Lenoir, North Carolina. Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. A total of 63 lots are now being recalled to the c (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 29, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Combination Treatment Beneficial in Albuminuric CKD
TUESDAY, Nov. 29, 2022 -- For patients with albuminuric chronic kidney disease (CKD) without diabetes, treatment with the combination of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and sodium-glucose cotransporter-2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures
First and only product approved for treating seizures in neonatal patients
Mumbai, India, November 18, 2022– Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 18, 2022 Category: Drugs & Pharmacology Source Type: news
NaF-PET shows bone formation in psoriatic arthritis patients
F-18 sodium fluoride (NaF) PET/CT may be a valuable tool for imaging patient...Read more on AuntMinnie.comRelated Reading:
NaF-PET reveals aortic wall injuries
NaF-PET scans reveal plaque -- and possible risk of stroke
NaF-PET/CT does well in detecting prostate metastases
NaF-PET/CT rarely finds prostate cancer bone metastases
AI algorithm can classify bone lesions on PET/CT images (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 18, 2022 Category: Radiology Source Type: news
Kids and sodium: Serious risks, alarming realities
When it comes to sodium intake among adults, the general consensus is that high consumption will increase risk of hypertension and stroke. According to the 2020 –2025 Dietary Guideline for Americans, 45% of people 18 and older are living with hypertension. Hypertension is a preventable risk factor for cardiovascular disease and stroke. Does a high sodium intake pose the same risks for children and adolescents as it does for adults? Children and adolescent s, ages 2–18, develop… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 8, 2022 Category: Databases & Libraries Source Type: news
Congress Resumes Asbestos Ban Efforts After ProPublica Report
This report confirms our worst fears. Workers dealing with asbestos are often left vulnerable to this deadly, dangerous substance.”
Merkley and U.S. Rep. Suzanne Bonamici, also of Oregon, are co-sponsoring the Alan Reinstein Ban Asbestos Now Act of 2022, which would ban any importation or use of asbestos. It is the most comprehensive asbestos ban legislation to come before Congress in more than 30 years. All previous legislative attempts have failed to advance.
Ban Asbestos Now Act Gains Co-Sponsors
This latest bill was filed in May and had one Senate committee hearing in June before it was shelved. Since the pu...
Source: Asbestos and Mesothelioma News - November 7, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Mesothelioma Source Type: news
IOL Chemicals gets EDQM certification for API supply to Europe
The European Directorate for the Quality of Medicines& HealthCare (EDQM) is a mandatory certification for distribution of any API/ pharma products in Europe. Pantoprazole Sodium Sesquihydrate, an active pharmaceutical ingredient (API), is proton pump inhibitor used in drugs to suppress the gastric acid secretion. "The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its Punjab-based facility. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 7, 2022 Category: Pharmaceuticals Source Type: news
What to Know About Diabetes and the Risk of Silent Heart Attacks
At first it seemed like a routine call—something the paramedics had dealt with countless times before. A man in his mid-50s was having a heart attack, and his physician had called for emergency support. But when the paramedics arrived, the physician pulled them aside and told them something peculiar: the man had no cardiovascular symptoms whatsoever.
The man had come to his doctor’s office because he’d woken early the previous morning sweating and with a sharp pain in his left wrist. These symptoms had quickly subsided and he’d gone back to sleep. Later, after going about his day, he’d visited...
Source: TIME: Health - November 4, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate heart health Source Type: news
Hydrogel With Sodium Alginate and Vitamins A and E for DFU Hydrogel With Sodium Alginate and Vitamins A and E for DFU
Could this new product offer any additional benefits in the treatment of diabetic foot ulcers? How does it compare with conventional dressings?Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2022 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Coping With the Side Effects of Kidney-Cancer Treatment
Not long ago, the treatment options available to people with metastatic kidney cancer were few and feeble. Surgical removal of the affected tissue was an effective and often durable fix for people with cancer that was confined to the kidneys. But for the roughly 30% to 40% of people with kidney cancer that spreads to other parts of the body, the prognosis was dispiritingly grim.
Fortunately, things are much different today. “Since the early 2000s, we’ve had a class of drugs called blood-vessel inhibitors, and these made an immediate impact,” says Dr. Primo Lara, a professor, clinician, and director of the...
Source: TIME: Health - October 27, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
